Evidence map›Paper›PMID 42553599›Full record

ReviewFrontiers in cardiovascular medicine2026

Precision approach for transradial access during PCI: a state-of-the-art review.

Tanawat Attachaipanich, Muzamil Khawaja, Hafeez Ul Hassan Virk, Dmitriy N Feldman, Elmir Omerovic, Ian C Gilchrist, Arnold H Seto, Chayakrit Krittanawong

Abstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tanawat AttachaipanichDepartment of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas city, MO, United States.
Muzamil KhawajaDepartment of Cardiology, Emory University, Atlanta, GA, United States.
Hafeez Ul Hassan VirkDivision of Cardiovascular Disease, Department of Medicine, Albert Einstein Healthcare Network, Philadelphia, PA, United States.
Dmitriy N FeldmanDivision of Cardiology, Interventional Cardiology and Endovascular Laboratory, Weill Cornell Medical College, New York-Presbyterian Hospital, New York, NY, United States.
Elmir OmerovicDepartment of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Ian C GilchristGeisel School of Medicine at Dartmouth, Section of Cardiovascular Medicine, Heart and Vascular Center, Dartmouth Hitchcock Medical Center, Hanover, NH, United States.
Arnold H SetoDepartment of Medicine, VA Long Beach Healthcare System, Long Beach, CA, United States.
Chayakrit KrittanawongHumanX, Delaware, DE, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transradial approach (TRA) has become the preferred vascular access for coronary angiography and percutaneous coronary intervention (PCI), offering reductions in bleeding and vascular complications compared with the transfemoral approach, and lower mortality in patients with acute coronary syndromes (ACS). Technical refinements have further enhanced procedural success with TRA. Variations in puncture technique (ultrasound-guidance, through-and-through vs. single-wall technique) and the use of vasodilator "radial cocktails" can improve access success and reduce the risk of radial artery spasm (RAS), while adequate anticoagulation, appropriate sheath sizing, and optimized radial band removal techniques help to reduce radial artery occlusion (RAO). Alternative access strategies such as distal radial (dTRA) and ulnar approaches offer advantages including lower RAO rates and preservation of the proximal radial artery for future conduit use, though these techniques are limited by higher crossover rates, longer cannulation times, and the need for additional operator experience. Optimal intraprocedural anticoagulation in the TRA era remains uncertain, as the bleeding advantage of alternatives to unfractionated heparin may be attenuated given the inherently lower access-site bleeding risk. Procedural complications, including hematoma, RAS, RAO warrant prevention and prompt recognition. Future research should refine anticoagulation strategies, personalize access-site selection, and further evaluate dTRA and ulnar approaches as operator experience matures.

Indexed as

acute coronary syndromespercutaneous coronary interventionradial accessradial artery occlusionradial artery spasmtransradial approach

Identifiers

PMID42553599
PMCPMC13435249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.